Chicago

Chicago Heights Pharma Glass Plant Shutters, 172 Jobs Axed As Work Heads Overseas

AI Assisted Icon
Published on April 27, 2026
Chicago Heights Pharma Glass Plant Shutters, 172 Jobs Axed As Work Heads OverseasSource: Google Street View

A longtime Chicago Heights manufacturer is getting ready to go dark, and 172 workers are set to lose their jobs as a result. Gerresheimer, the German maker of pharmaceutical glass and drug-delivery components, plans to close its moulded-glass plant in the south suburb this year, with company filings showing that separations are scheduled for Sept. 30 and moulded Type I production will be moved to Gerresheimer facilities abroad. Management is framing the shutdown as part of a broader effort to streamline operations and cut costs.

Layoff notice and timeline

A notice filed with the Illinois Department of Commerce and Economic Opportunity on April 13 lists 172 employees as affected and sets Sept. 30 as the separation date, according to the Peoria Journal Star. The filing formalizes the company’s WARN notice to state officials and to workers at the Chicago Heights site, putting a firm date on when jobs will end.

Company frames closure as a cost-saving move

Gerresheimer says the Chicago Heights shutdown is one of several moves in its global “transformation program” that are meant to reduce costs and improve overall performance. The company plans to transfer the moulded-glass business to three Type I plants in Italy and India. That plan was laid out in a Feb. 10 corporate release that also described planned asset sales and capacity consolidation; the company statement from Gerresheimer AG spells out the restructuring in more detail.

Restructuring comes amid accounting and reporting trouble

The plant closure is unfolding against a backdrop of financial and reporting headaches for the company. Earlier this year, Gerresheimer postponed publication of its 2025 annual and consolidated financial statements and brought in additional reviews of revenue recognition and accounting practices. It has also warned of sizeable non-cash impairments tied to its moulded-glass operations. Executives and analysts have described these steps as part of a broader push to shore up liquidity and streamline the business, according to coverage summarized by Investing.com.

What workers and the community can expect

Under Illinois’ WARN rules, employers planning a plant closing of this scale must notify the state and local officials and provide at least 60 days’ advance notice. That notice typically sets off Rapid Response and layoff-assistance services through the state workforce system. Workers affected by the Chicago Heights closure are usually eligible for unemployment benefits and for state-run retraining or job-placement programs while the facility winds down. Guidance and support resources are available through the Illinois Department of Commerce and Economic Opportunity.

Plant background and next steps

The Chicago Heights plant has long produced Type I moulded glass used in vials, serum bottles and other pharmaceutical containers, and Gerresheimer lists the site and its capabilities on its corporate website. The company says the facility will close by the end of its 2026 financial year as part of the transformation program, meaning suppliers and employees face several months of transition while production is shifted overseas. For technical details about the plant and its role in the company’s network, see the location page from Gerresheimer.